Hemogenyx Pharmaceuticals
Hemogenyx clears FDA hurdle for its novel CAR-T therapy for AML
Anika Sharma
Hemogenyx Pharmaceuticals has moved a step closer to advancing its CAR-T therapy, HEMO-CAR-T, into clinical trials following the FDA’s acceptance ...
